Find clinical trials for Ovarian Cancer in Berlin, BE
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Berlin, BE, DEU:
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Berlin, Germany and 213 other locations
of Estrogen-receptor (ER) positive high and low grade epithelial ovarian cancer (including fallopian tube and primary peritoneal ca...
Phase 3
Berlin, Germany and 53 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Berlin, Germany and 125 other locations
to chemotherapy and in maintenance, in patients with low grade ovarian cancer (including patients with primary peritoneal and / or...
Phase 2
Berlin, Germany and 1 other location
of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian...
Phase 3
Berlin, Germany and 92 other locations
study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already ...
Phase 3
Berlin, Germany and 143 other locations
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....
Phase 2
Berlin, Berlin, Germany and 55 other locations
This is a multi-center, prospective, open-label, phase II trial. Patients with suspected advanced ovarian cancer planned to undergo...
Phase 2
Berlin, State of Berlin, Germany and 5 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Berlin, Germany and 104 other locations
with either niraparib or lartesertib in participants with epithelial ovarian cancer and to assess any differences between tuvuserti...
Phase 2
Berlin, Germany and 83 other locations
Clinical trials
Research sites
Resources
Legal